Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma
Open Access
- 5 September 2023
- journal article
- letter
- Published by Springer Nature in Blood Cancer Journal
- Vol. 13 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disordersLeukemia, 2021
- International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLeukemia, 2020
- Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune ProfilingTransplantation and Cellular Therapy, 2020
- European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and whenHaematologica, 2018
- Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingLeukemia, 2018
- MRD in multiple myeloma: more questions than answers?Blood Cancer Journal, 2017
- Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical TrialsJournal of Clinical Oncology, 2017
- Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingNature Communications, 2017
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myelomaLeukemia, 2017
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014